James Helliwell
Patrimonio netto: 7 M $ in data 31/07/2026
Patrimonio netto: 7 M $ in data 31/07/2026
James A. Helliwell is the founder of Eupraxia Pharmaceuticals, Inc., founded in 2011, where Dr. Helliwell holds the titles of Chief Executive Officer & Director.
Dr. Helliwell is also the founder of Accuro Technologies, Inc...
Dr. Helliwell is currently the Chairman at Guidestar Medical Devices.
Formerly, Dr. Helliwell was an Assistant Professor at the University of British Columbia.
Dr. Helliwell completed undergraduate education at the University of British Columbia.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/06/2026 | 1.055.012 ( 1,61% ) | 7 M $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| EUPRAXIA PHARMACEUTICALS INC. | Fondatore | 12/05/2011 |
Guidestar Medical Devices
Guidestar Medical Devices Medical SpecialtiesHealth Technology Designs and manufactures medical devices | Presidente | - |
Accuro Technologies, Inc. | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Eupraxia Pharmaceuticals, Inc.
Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accuro Technologies, Inc. | |
Guidestar Medical Devices
Guidestar Medical Devices Medical SpecialtiesHealth Technology Designs and manufactures medical devices | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale